Fluoguide AS
STO:FLUO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
33.9
75.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Fluoguide AS
Total Current Assets
Fluoguide AS
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fluoguide AS
STO:FLUO
|
Total Current Assets
kr28.3m
|
CAGR 3-Years
21%
|
CAGR 5-Years
227%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Total Current Assets
kr21.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
23%
|
CAGR 10-Years
23%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Total Current Assets
kr8.7B
|
CAGR 3-Years
88%
|
CAGR 5-Years
41%
|
CAGR 10-Years
38%
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Total Current Assets
€973.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
58%
|
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Total Current Assets
kr5.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
23%
|
CAGR 10-Years
23%
|
|
|
Bioporto A/S
CSE:BIOPOR
|
Total Current Assets
kr123.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
Fluoguide AS
Glance View
FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.
See Also
What is Fluoguide AS's Total Current Assets?
Total Current Assets
28.3m
DKK
Based on the financial report for Dec 31, 2023, Fluoguide AS's Total Current Assets amounts to 28.3m DKK.
What is Fluoguide AS's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
227%
Over the last year, the Total Current Assets growth was -19%. The average annual Total Current Assets growth rates for Fluoguide AS have been 21% over the past three years , 227% over the past five years .
You don't have any saved screeners yet
